The information on this page is for informational purposes only and does not constitute medical advice. Consult your genetic counselor or specialist physician for treatment decisions.

TERT

—Telomerase Reverse Transcriptase

Chromosome: 5

Location: 5:1253147-1295085

OMIM: 187270

Ensembl: ENSG00000164362

Official·OMIM:187270 Official·ENSG00000164362

Encodes telomerase reverse transcriptase. Mutations cause dyskeratosis congenita and aplastic anemia.

Treatment Roadmap — TERT

Preclinical

Phase 1

Phase 2

Phase 3

1 trial

Approved

Clinical trials have approximately 10% success rate. This roadmap shows the current status, not guaranteed outcomes.

Associated Diseases

Dyskeratosis Congenita

Autosomal DominantPrevalence: 1/1000000hematologic

Official·OMIM:305000 Official·ORPHA1775

Summary

Clinical Trial

Approved Therapy

Registered Variant